Fundraising Fox

Simbryotech

Houston, US · Founded 2023 · 1 known investors

Simbryo Technologies is a biotech company that creates endometrial organoids from a patient's own stem cells using a routine biopsy, offering functional diagnostic tests of the uterine lining to assess and optimize endometrial fertility. Working with research institutions and fertility clinics, it uses organoid medicine and AI to give patients and physicians insights aimed at improving IVF success rates and to serve as a test bed for new fertility treatments.

Founders & leadership

YK
Yael KatzNamed on SEC filing
AW
Aryeh WarmflashNamed on SEC filing
SR
Stephen RooksNamed on SEC filing
AM
Andrea MazzocchiNamed on SEC filing

Investors · 1

Reported raises · per SEC filings

Form D private placements

$5.3M disclosed across 1 of 2 rounds · 2025–2026

$5.3MraisedJul 2026 · 24 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Yael KatzExecutive Officer, Director
  • Aryeh WarmflashExecutive Officer
  • Stephen RooksDirector
  • Andrea MazzocchiDirector
Offering amount
$5.3M
Amount sold
$5.3M
First sale
Sep 2025
Incorporated
Corporation, Delaware, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 5

by search overlap

Companies competing with Simbryotech for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frequently asked questions

What does Simbryotech do?
Simbryo Technologies is a biotech company that creates endometrial organoids from a patient's own stem cells using a routine biopsy, offering functional diagnostic tests of the uterine lining to assess and optimize endometrial fertility. Working with research institutions and fertility clinics, it uses organoid medicine and AI to give patients and physicians insights aimed at improving IVF success rates and to serve as a test bed for new fertility treatments.
Who are Simbryotech's investors?
Simbryotech's investors include TSVC.
How much funding has Simbryotech raised?
Simbryotech has disclosed $5.3M raised across 1 of its 2 known rounds.
Where is Simbryotech headquartered?
Simbryotech is headquartered in Houston, US.